{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T17:38:42Z","timestamp":1771522722044,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274312"],"award-info":[{"award-number":["82274312"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.intimp.2025.116046","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T17:07:44Z","timestamp":1767719264000},"page":"116046","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Integrating single-cell and bulk RNA sequencing to identify disulfidptosis-related gene signature, immune landscape, and immunotherapy targets in cutaneous melanoma"],"prefix":"10.1016","volume":"171","author":[{"given":"Zhen","family":"Yi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaozhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinjing","family":"Che","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.intimp.2025.116046_bb0005","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/annonc\/mdz411","article-title":"Cutaneous melanoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Michielin","year":"2019","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2025.116046_bb0010","doi-asserted-by":"crossref","first-page":"7250","DOI":"10.1038\/s41467-022-34877-3","article-title":"A single-cell analysis reveals tumor heterogeneity and immune environment of acral melanoma","volume":"13","author":"Chao","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2025.116046_bb0015","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/jamadermatol.2018.3964","article-title":"Association of Phenotypic Characteristics and UV radiation exposure with risk of melanoma on different body sites","volume":"155","author":"Reza","year":"2019","journal-title":"JAMA Dermatol."},{"issue":"5","key":"10.1016\/j.intimp.2025.116046_bb0020","first-page":"E32","article-title":"New therapies in melanoma: current trends, evolving paradigms, and future perspectives","volume":"112","author":"Saba","year":"2023","journal-title":"Cutis"},{"issue":"22","key":"10.1016\/j.intimp.2025.116046_bb0025","doi-asserted-by":"crossref","first-page":"20783","DOI":"10.1002\/cam4.6645","article-title":"Real-world outcomes of 18,186 metastatic solid tumor outpatients: baseline blood cell counts correlate with survival after immune checkpoint inhibitor therapy","volume":"12","author":"Goldschmidt Jerome","year":"2023","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.116046_bb0030","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12943-020-01238-x","article-title":"Natural killer cells in cancer biology and therapy","volume":"19","author":"Wu Song-Yang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.intimp.2025.116046_bb0035","doi-asserted-by":"crossref","first-page":"1126661","DOI":"10.3389\/fendo.2023.1126661","article-title":"Non-apoptotic programmed cell deaths in diabetic pulmonary dysfunction: the new side of advanced glycation end products","volume":"14","author":"Yimin","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.intimp.2025.116046_bb0040","doi-asserted-by":"crossref","first-page":"1252567","DOI":"10.3389\/fphar.2023.1252567","article-title":"Ferroptosis as a promising therapeutic strategy for melanoma","volume":"14","author":"Na","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2025.116046_bb0045","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41556-023-01091-2","article-title":"Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis","volume":"25","author":"Xiaoguang","year":"2023","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.intimp.2025.116046_bb0050","article-title":"Fostered Nrf2 expression antagonizes iron overload and glutathione depletion to promote resistance of neuron-like cells to ferroptosis","volume":"407","author":"Zixuan","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.intimp.2025.116046_bb0055","series-title":"Disulfidptosis in tumor progression. Cell Death Discov","volume":"11","author":"Senlin","year":"2025"},{"key":"10.1016\/j.intimp.2025.116046_bb0060","article-title":"A novel FTO-targeting nanodrug induces disulfidptosis and ameliorates the suppressive tumor immune environment to treat uveal melanoma","volume":"319","author":"Hao","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.intimp.2025.116046_bb0065","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejca.2021.03.005","article-title":"Applications of single-cell and bulk RNA sequencing in onco-immunology","volume":"149","author":"Maria","year":"2021","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2025.116046_bb0070","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s13059-023-03123-4","article-title":"Challenges and opportunities to computationally deconvolve heterogeneous tissue with varying cell sizes using single-cell RNA-sequencing datasets","volume":"24","author":"Maden Sean","year":"2023","journal-title":"Genome Biol."},{"key":"10.1016\/j.intimp.2025.116046_bb0075","article-title":"CEBPB is associated with active tumor immune environment and favorable prognosis of metastatic skin cutaneous melanoma","volume":"13","author":"Yang Jingrun","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.116046_bb0080","article-title":"iRegulon: from a gene list to a gene regulatory network using large motif and track collections","volume":"10","author":"Rekin\u2019s","year":"2014","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.intimp.2025.116046_bb0085","first-page":"5146982","article-title":"Nrf2 and STAT3 alleviates Ferroptosis-mediated IIR-ALI by regulating SLC7A11","volume":"2020","author":"Zhuanzhuan","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.intimp.2025.116046_bb0090","article-title":"Immune-and metabolism-associated molecular classification of ovarian Cancer","volume":"12","author":"Zhenyue","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.intimp.2025.116046_bb0095","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.cell.2023.03.007","article-title":"T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants","volume":"186","author":"Daniel","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2025.116046_bb0100","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejca.2023.04.008","article-title":"Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma: a multicenter dermatologic cooperative oncology group study on 637 patients from the prospective skin cancer registry ADOREG","volume":"188","author":"Anne","year":"2023","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.intimp.2025.116046_bb0105","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejca.2023.03.003","article-title":"Surgical outcomes of lymph node dissections for stage III melanoma after neoadjuvant systemic therapy are not inferior to upfront surgery","volume":"185","author":"Zijlker Lisanne","year":"2023","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.intimp.2025.116046_bb0110","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1186\/s12885-023-11521-x","article-title":"Exploration and validation of a novel signature of seven necroptosis-related genes to improve the clinical outcome of hepatocellular carcinoma","volume":"23","author":"Qiqi","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.intimp.2025.116046_bb0115","article-title":"Systematic analysis of the cuprotosis in tumor microenvironment and prognosis of gastric cancer","volume":"9","author":"Ke-Wei","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.intimp.2025.116046_bb0120","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.semcancer.2020.09.010","article-title":"The effect of caloric restriction and fasting on cancer","volume":"73","author":"Mona","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.intimp.2025.116046_bb0125","doi-asserted-by":"crossref","first-page":"eaax7881","DOI":"10.1126\/sciadv.aax7881","article-title":"Inhibition of Vps34 reprograms cold into hot inflamed tumors and improves anti-PD-1\/PD-L1 immunotherapy","volume":"6","author":"Zaeem","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.intimp.2025.116046_bb0130","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1158\/2159-8290.CD-19-0672","article-title":"Mutant BRAF and MEK inhibitors regulate the tumor immune microenvironment via Pyroptosis","volume":"10","author":"Erkes Dan","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.intimp.2025.116046_bb0135","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41573-023-00749-8","article-title":"The therapeutic potential of targeting regulated non-apoptotic cell death","volume":"22","author":"Kamyar","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.intimp.2025.116046_bb0140","article-title":"Molecular landmarks of tumor disulfidptosis across cancer types to promote disulfidptosis-target therapy","volume":"68","author":"Deze","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.intimp.2025.116046_bb0145","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/s41556-018-0178-0","article-title":"BAP1 links metabolic regulation of ferroptosis to tumour suppression","volume":"20","author":"Yilei","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.intimp.2025.116046_bb0150","article-title":"Systems-level network modeling deciphers the master regulators of phenotypic plasticity and heterogeneity in melanoma","volume":"24","author":"Maalavika","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.intimp.2025.116046_bb0155","doi-asserted-by":"crossref","first-page":"22218","DOI":"10.1038\/s41598-023-49752-4","article-title":"Bioinformatics-based analysis of the relationship between disulfidptosis and prognosis and treatment response in pancreatic cancer","volume":"13","author":"Yuanpeng","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2025.116046_bb0160","article-title":"Role of disulfidptosis in colorectal adenocarcinoma: implications for prognosis and immunity","volume":"15","author":"Ruanruan","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.intimp.2025.116046_bb0165","article-title":"Disulfidptosis related immune genes drive prognostic model development and tumor microenvironment characterization in bladder urothelial carcinoma","volume":"15","author":"Shenchao","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.intimp.2025.116046_bb0170","doi-asserted-by":"crossref","first-page":"1198826","DOI":"10.3389\/fimmu.2023.1198826","article-title":"Identification of disulfidptosis-related subtypes, characterization of tumor microenvironment infiltration, and development of a prognosis model in breast cancer","volume":"14","author":"Jiahui","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.116046_bb0175","doi-asserted-by":"crossref","first-page":"1207068","DOI":"10.3389\/fonc.2023.1207068","article-title":"An integrative multi-omics analysis based on disulfidptosis-related prognostic signature and distinct subtypes of clear cell renal cell carcinoma","volume":"13","author":"Dong","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.intimp.2025.116046_bb0180","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41556-020-0496-x","article-title":"Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer","volume":"22","author":"Xiaoguang","year":"2020","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.intimp.2025.116046_bb0185","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s10020-023-00739-x","article-title":"Leveraging a disulfidptosis-related signature to predict the prognosis and immunotherapy effectiveness of cutaneous melanoma based on machine learning","volume":"29","author":"Yi","year":"2023","journal-title":"Mol. Med."},{"key":"10.1016\/j.intimp.2025.116046_bb0190","doi-asserted-by":"crossref","first-page":"1198878","DOI":"10.3389\/fimmu.2023.1198878","article-title":"Leveraging a disulfidptosis-based signature to improve the survival and drug sensitivity of bladder cancer patients","volume":"14","author":"Hualin","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.116046_bb0195","article-title":"Lung tumor-infiltrating T have divergent transcriptional profiles and function linked to checkpoint blockade response","volume":"8","author":"Dykema Arbor","year":"2023","journal-title":"Sci Immunol"},{"key":"10.1016\/j.intimp.2025.116046_bb0200","doi-asserted-by":"crossref","first-page":"1321596","DOI":"10.3389\/fimmu.2023.1321596","article-title":"Fine-tuning the antigen sensitivity of CAR T cells: emerging strategies and current challenges","volume":"14","author":"Christoph","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.116046_bb0205","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.canlet.2021.06.008","article-title":"Beta2-microglobulin(B2M) in cancer immunotherapies: biological function, resistance and remedy","volume":"517","author":"Hanbing","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2025.116046_bb0210","first-page":"3","article-title":"Major histocompatibility complex and hematopoietic stem cell transplantation: beyond the classical HLA polymorphism","volume":"19","author":"Alice","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.116046_bb0215","article-title":"Expression of MHC class I, HLA-A and HLA-B identifies immune-activated breast tumors with favorable outcome","volume":"8","author":"Del Mar","year":"2019","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.intimp.2025.116046_bb0220","article-title":"Identification of human MHC-I HPV18 E6\/E7-specific CD8+T cell epitopes and generation of an HPV18 E6\/E7-expressing adenosquamous carcinoma in HLA-A2 transgenic mice","volume":"29","author":"Shiwen","year":"2022","journal-title":"J Biomed. Sci."},{"key":"10.1016\/j.intimp.2025.116046_bb0225","article-title":"Polymorphisms of HLA-B: influences on assembly and immunity","volume":"64","author":"Eli","year":"2020","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.intimp.2025.116046_bb0230","article-title":"Tumor endothelial cell autophagy is a key vascular-immune checkpoint in melanoma","volume":"15","author":"Jelle","year":"2023","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.intimp.2025.116046_bb0235","article-title":"High SLC7A11 expression in normal skin of melanoma patients","volume":"62","author":"Ismael","year":"2019","journal-title":"Cancer Epidemiol"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925020351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925020351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T16:58:14Z","timestamp":1771520294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925020351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":47,"alternative-id":["S1567576925020351"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.116046","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrating single-cell and bulk RNA sequencing to identify disulfidptosis-related gene signature, immune landscape, and immunotherapy targets in cutaneous melanoma","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.116046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116046"}}